Back to results
Active, not recruiting

Impact of BMI on CDK4/6 Inhibitors Efficacy and Safety in Advanced Breast Cancer

NCT06926088

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Jiangsu Provincial People's Hospital

Nanjing, Jiangsu, China

View on ClinicalTrials.gov
Impact of BMI on CDK4/6 Inhibitors Efficacy and Safety in Advanced Breast Cancer — TrialFind